Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Shear

Showing results (91-100 of 192) with videos related to

Pageof 20
Sort By:
AIDS (London, England)|November 1, 2002
Utility of patch testing in patients with hypersensitivity syndromes associated with abacavirElizabeth J Phillips, John R Sullivan, Sandra R Knowles, et al.
Journal of the American Academy of Dermatology|May 7, 2018
Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective studyArvin Ighani, Jorge R Georgakopoulos, Neil H Shear, et al.
Archives of Dermatology|July 20, 2005
Pseudoephedrine-induced toxic epidermal necrolysisJeffrey J Nagge, Sandra R Knowles, David N Juurlink, et al.
Journal of the American Academy of Dermatology|October 12, 2017
Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Neil H Shear, et al.
Clinical Biochemistry|April 9, 2002
Mechanism of Impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cellsAlpa Popat, Neil H Shear, Izabella Malkiewicz, et al.
Journal of the American Academy of Dermatology|October 10, 2017
A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Scott Walsh, et al.
Drug Safety|January 23, 2016
The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015Roni P Dodiuk-Gad, Cristina Olteanu, Wen-Hung Chung, et al.
American Journal of Clinical Dermatology|June 19, 2017
Drug-Induced Pyoderma Gangrenosum: A ReviewJane Y Wang, Lars E French, Neil H Shear, et al.
Journal of the American Academy of Dermatology|January 31, 2006
Socioeconomic status influences care of patients with acne in Ontario, CanadaAamir Haider, Muhammad Mamdani, James C Shaw, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Pageof 20

Showing results (91-100 of 192) with videos related to

Sort By:
Pageof 20
AIDS (London, England)|November 1, 2002
Utility of patch testing in patients with hypersensitivity syndromes associated with abacavirElizabeth J Phillips, John R Sullivan, Sandra R Knowles, et al.
Journal of the American Academy of Dermatology|May 7, 2018
Maintenance of therapeutic response after 1 year of apremilast combination therapy compared with monotherapy for the treatment of plaque psoriasis: A multicenter, retrospective studyArvin Ighani, Jorge R Georgakopoulos, Neil H Shear, et al.
Archives of Dermatology|July 20, 2005
Pseudoephedrine-induced toxic epidermal necrolysisJeffrey J Nagge, Sandra R Knowles, David N Juurlink, et al.
Journal of the American Academy of Dermatology|October 12, 2017
Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Neil H Shear, et al.
Clinical Biochemistry|April 9, 2002
Mechanism of Impila (Callilepis laureola)-induced cytotoxicity in Hep G2 cellsAlpa Popat, Neil H Shear, Izabella Malkiewicz, et al.
Journal of the American Academy of Dermatology|October 10, 2017
A comparison of apremilast monotherapy and combination therapy for plaque psoriasis in clinical practice: A Canadian multicenter retrospective studyArvin Ighani, Jorge R Georgakopoulos, Scott Walsh, et al.
Drug Safety|January 23, 2016
The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015Roni P Dodiuk-Gad, Cristina Olteanu, Wen-Hung Chung, et al.
American Journal of Clinical Dermatology|June 19, 2017
Drug-Induced Pyoderma Gangrenosum: A ReviewJane Y Wang, Lars E French, Neil H Shear, et al.
Journal of the American Academy of Dermatology|January 31, 2006
Socioeconomic status influences care of patients with acne in Ontario, CanadaAamir Haider, Muhammad Mamdani, James C Shaw, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE studyGordon Searles, Robert Bissonnette, Ian Landells, et al.
Pageof 20